Madrigal: More Than 55,850 Patients On Rezdiffra As Of Sept. 30, Nearly Double YoY
Share
Why It Matters
Madrigal's weight loss drug Rezdiffra now has almost twice as many patients. When a medicine grows this fast, it shows doctors trust it and sales may keep climbing.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.